About Tilray Brands, Inc.
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, Latin America, with growing facilities in Germany, Portugal and the United Kingdom. In December 2020, the company announced a merger with Aphria, and now operates under the Tilray name and its ticker symbol on NASDAQ and the Toronto Stock Exchange.
2BB score and signals
Tilray Brands, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 58 | Moderate |
| Momentum | 68 | Improving |
| Financial strength | 28 | Weak |
| Quality | 100 | Very Strong |
| Risk | 40 | Low |
Company facts
| CEO | Irwin D.Simon |
| Headquarters | New York, New York, Canada |
| Founded | 2013 |
| Employees | 3.6K |
| 52-week range | $3.67 – $23.20 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-01-06 | — | -0.2169 | — | $279.04M |
| 2026-10-07 | — | -0.1948 | — | $275.82M |
| 2026-07-28 | — | -0.0068 | — | $249.48M |
| 2026-04-01 | -0.24 | -0.1428 | $206.73M | $205.38M |
Related companies
